Inverse Correlation between Cancer Size and Abdominal Obesity in Colorectal Cancer Cases

  • Jeong, Taek Gun (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Kim, Ji Wan (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Lee, Sun-Young (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Park, Hee Sun (Department of Radiology, Konkuk University School of Medicine) ;
  • Han, Hye Seung (Department of Pathology, Konkuk University School of Medicine) ;
  • Hwang, Dae Yong (Department of Surgery, Konkuk University School of Medicine)
  • Published : 2016.08.01


Background: Correlation between colorectal cancer (CRC) and abdominal obesity has been established, but there is a paucity of data on non-obese CRC patients. The aim of this study was to establish the characteristics of CRCs that occur in such patients. Materials and Methods: Consecutive CRC patients without cachexia were included. Unintended body weight loss, T4- or M1-staged CRCs, extensive lymph node involvement, or synchronous malignancy were classified as cachectic conditions. Abdominal fat volumes were measured using a multidetector CT unit with a software (Rapidia, INFINITT, Seoul, Korea). Results: Of the newly-diagnosed CRC patients, 258 non-cachectic and 88 cachectic patients were analyzed. The cancer size (p<0.001) and T stage (p<0.001) were inversely correlated with body mass index (BMI), visceral fat and subcutaneous fat volumes. Cancer size was the only independent factor related to BMI (p=0.016), visceral fat volume (p=0.002), and subcutaneous fat volume (p=0.027). In non-cachectic patients, a significant inverse correlation was found only between the cancer size and visceral fat volume (p=0.017). Conclusions: Non-obese CRC patients tend to have larger CRC lesions than their obese counterparts even under non-cachectic conditions. Such an inverse correlation between cancer size and visceral fat volume suggests that considerable CRCs are not correlated with abdominal obesity.


Supported by : Konkuk University


  1. Aleksandrova K, Pischon T, Buijsse B, et al (2013). Adult weight change and risk of colorectal cancer in the european prospective investigation into cancer and Nutrition. Eur J Cancer, 49, 3526-36.
  2. Bardou M, Barkun AN, Martel M (2013). Obesity and colorectal cancer. Gut, 62, 933-47.
  3. Chacko L, Macaron C, Burke CA (2015). Colorectal cancer screening and prevention in women. Dig Dis Sci, 60, 698-710.
  4. Chung HW, Lee SY, Han HS, et al (2013). Gastric cancers with microsatellite instability exhibit higher standard uptake value on FDG-PET imaging study. Gastric Cancer, 16, 185-92.
  5. Frezza EE, Wachtel MS, Chiriva-Internati M (2006). Influence of obesity on the risk of developing colon cancer. Gut, 55, 285-91.
  6. Goh LY, Goh KL (2013). Obesity: an epidemiological perspective from Asia and its relationship to gastrointestinal and liver cancers. J Gastroenterol Hepatol, 28, 54-8.
  7. Hong S, Cai Q, Chen D, et al (2012). Abdominal obesity and the risk of colorectal adenoma: a meta-analysis of observational studies. Eur J Cancer Prev, 21, 523-31.
  8. Kaneko R, Nakazaki N, Tagawa T, et al (2014). A new index of abdominal obesity which effectively predicts risk of colon tumor development in female Japanese. Asian Pac J Cancer Prev, 15, 1005-10.
  9. Kim BC, Shin A, Hong CW, et al (2012). Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control, 23, 727-35.
  10. Kim KS, Moon HJ, Choi CH, et al (2010). The frequency and risk factors of colorectal adenoma in health-check-up patients in South Korea: relationship to abdominal obesity and age. Gut Liver, 4, 36-42.
  11. Kim SE, Shim KN, Jung SA, et al (2007). An association between obesity and the prevalence of colonic adenoma according to age and gender. J Gastroenterol, 42, 616-23.
  12. Kim Y, Kim Y, Lee S (2009). An association between colonic adenoma and abdominal obesity: a cross-sectional study. BMC Gastroenterol, 9, 4.
  13. Lee JK, Hahn SJ, Kang HW, et al (2016). Visceral obesity is associated with gallbladder polyps. Gut Liver, 10, 133-9.
  14. Lee SY, Chung H, Deveraj B, et al (2010). Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias. Gastroenterol, 139, 1519-25.
  15. Lysaght J, van der Stok EP, Allott EH, et al (2011). Proinflammatory and tumor proliferative properties of excess visceral adipose tissue. Cancer Lett, 312, 62-72.
  16. Nagata N, Sakamoto K, Arai T, et al (2014). Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma. Int J Cancer, 135, 2273-81.
  17. Park SW, Lee HL, Doo EY, et al (2015). Visceral obesity predicts fewer lymph node Metastases and better overall survival in colon cancer. J Gastrointest Surg, 19, 1513-21.
  18. Rickles AS, Iannuzzi JC, Mironov O, et al (2013). Visceral obesity and colorectal cancer: are we missing the boat with BMI? J Gastrointest Surg, 17, 133-43.
  19. Song YM, Sung J, Ha M (2008). Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol, 26, 3395-402.
  20. Sung MK, Yeon JY, Park SY, et al (2011). Obesity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci, 1229, 61-8.
  21. Watanabe S, Hojo M, Nagahara A (2007). Metabolic syndrome and gastrointestinal diseases. J Gastroenterol, 42, 267-74.